Delivery Order SPE2DB24D2011-SPE2DB25FBRWC
- Not listed
- The Defense Logistics Agency awarded a $1,185.57 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Belsomra 20 mg, a pharmaceutical product for treating insomnia. This competitively awarded, firm fixed-price contract was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and involves performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,069.68 to AmerisourceBergen Drug Corp for 30 tablets of Belsomra 10 mg on July 30, 2025. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order, with an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The award represents a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract award from the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Belsomra 20 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $1,181.89 and an ultimate completion date of July 23, 2025. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Belsomra 20 mg tablets (30-count packages) valued at $1,833.31. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Belsomra 20 mg tablets in a quantity of 30 units, with a contract ceiling value of $1,811.34. This competitively awarded, firm fixed-price delivery order is not subject to any small business set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and is scheduled for completion by September 11,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Belsomra 20 mg tablets (30-count units) under a firm fixed-price contract valued at $1,488.99. This non-set-aside award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026 that supports global pharmaceutical supply to...
- This federal contract award, valued at $2,366.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Belsomra 10 mg tablets, a medication used to treat insomnia. The contract is a Delivery Order under a Firm Fixed Price arrangement, with an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Belsomra 10 mg tablets. The firm-fixed-price contract has a ceiling value of $1,179.37 and a completion date of August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to support federal healthcare programs and services. The contract is not set-aside and is part of a larger Indefinite Delivery...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,390.28 firm fixed-price contract is for the supply of Belsomra 10mg tablets, a prescription medication used to treat insomnia. The award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This delivery order, awarded June 30, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Belsomra 20 mg tablets (30-count units) with a ceiling value of $1,058.07. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRWCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $2,674.38 to supply 30 tablets of Belsomra 10 mg, a prescription medication used to treat insomnia. This firm fixed price contract was competitively awarded without any set-aside designation and has an ultimate completion date of September 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a major pharmaceutical distributor for DoD medical supply chains, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/16/25 |